Table 2.

Comparison of blood lipid levels between groups before and after treatment

Variable		Control group (n=55)	PCSK9 inhibitor group (n=55)	t	P
TG (mmol/L)	Before treatment	1.86±0.87	1.84±0.96	0.115	0.909
	After treatment	1.52±0.73	1.21±0.81	2.108	0.037
	t	2.220	3.719
	P	0.029	<0.001
TC (mmol/L)	Before treatment	5.78±1.15	5.81±1.35	-0.126	0.900
	After treatment	4.61±1.04	3.67±1.03	4.7627	<0.001
	t	5.596	9.346
	P	<0.001	<0.001
HDL-C (mmol/L)	Before treatment	1.04±0.27	1.05±0.29	-0.187	0.852
	After treatment	1.15±0.24	1.21±0.25	-1.284	0.202
	t	-2.258	-3.099
	P	0.026	0.003
LDL-C (mmol/L)	Before treatment	3.94±0.76	3.87±1.17	0.372	0.711
	After treatment	2.51±0.86	1.82±0.97	3.947	<0.001
	t	9.240	10.003
	P	<0.001	<0.001
Lp(a) (mg/L)	Before treatment	321.23±102.43	320.78±100.96	0.023	0.982
	After treatment	318.87±97.23	241.93±94.45	4.210	<0.001
	t	0.124	4.230
	P	0.902	<0.001

Note: All data are presented mean ± SD. Abbreviations: HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; Lp(a), lipoprotein(a); PCSK9, proprotein convertase subtilisin/kexin 9; TC, total cholesterol; TG, triglycerides.